SCHEMBL445046

SCHEMBL445046

Clc1oc2ccccc2c1Cl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.56
MAPT P10636 5/20 0.56
SMN1; SMN2 Q16637 4/20 0.56
HSD17B10 Q99714 2/20 0.56
LMNA P02545 2/20 0.56
NPSR1 Q6W5P4 2/20 0.56
CYP1A2 P05177 2/20 0.56
GMNN O75496 1/20 0.56
TP53 P04637 1/20 0.56
POLB P06746 1/20 0.56
ELANE P08246 1/20 0.56
CTSG P08311 1/20 0.56
CTSA P10619 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C9 P11712 1/20 0.56
ALOX15 P16050 1/20 0.56
NFKB1 P19838 1/20 0.56
CYP2C19 P33261 1/20 0.56
THPO P40225 1/20 0.56
MTOR P42345 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyrazine SCHEMBL28381839 0.89 ALDH1A1 (0.47) ALDH1A1MAPTSMN1; SMN2HSD17B10LMNA
SCHEMBL31550331 0.82 ADORA3 (0.62) ALDH1A1MAPTSMN1; SMN2HSD17B10LMNA
SCHEMBL6013143 0.76 AHR (0.46) ALDH1A1MAPTSMN1; SMN2HSD17B10LMNA
SCHEMBL21035694 0.76 KDM4E (0.55) ALDH1A1MAPTSMN1; SMN2HSD17B10LMNA
SCHEMBL22247986 0.76 AHR (0.46) ALDH1A1MAPTSMN1; SMN2HSD17B10LMNA
SCHEMBL31450995 0.76 AHR (0.45) ALDH1A1MAPTSMN1; SMN2HSD17B10LMNA
SCHEMBL29155467 0.76 AHR (0.46) ALDH1A1MAPTSMN1; SMN2HSD17B10LMNA
SCHEMBL2540914 0.75 ALDH1A1 (0.53) ALDH1A1MAPTSMN1; SMN2HSD17B10LMNA
Dibenzofuran SCHEMBL8207 0.72 MAPT (0.68) ALDH1A1MAPTSMN1; SMN2HSD17B10CYP1A2
Dibenzofuran SCHEMBL9868133 0.72 MAPT (0.68) ALDH1A1MAPTSMN1; SMN2HSD17B10CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107118625-A Mould the preparation method of rattan article antioxidant coating 安徽持家汉家居工艺品有限公司 2017-09-01 CN claimed
CN-107099193-A It is a kind of to mould the preparation method that rattan hanging basket uses coating 安徽持家汉家居工艺品有限公司 2017-08-29 CN claimed
CN-107027836-A Mould the preparation method of rattan article maintaining agent 安徽持家汉家居工艺品有限公司 2017-08-11 CN claimed
CN-117224589-A Traditional Chinese medicine preparation for preventing Alzheimer disease as well as preparation method and application thereof 深圳华中科技大学研究院 2023-12-15 CN disclosed
CN-110073510-A LIGHT-EMITTING ELEMENT, ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE 株式会社半导体能源研究所 2019-07-30 CN disclosed
CN-107922311-A Organic electric element compound, organic electric element and its electronic device using it 德山新勒克斯有限公司 2018-04-17 CN disclosed
CN-107207488-A It is used as the bicyclic heteroaryl heteroaryl benzoic acid compounds of retinoic acid receptors β (RAR β) activator 伦敦皇家学院 2017-09-26 CN disclosed
CN-107118625-A Mould the preparation method of rattan article antioxidant coating 安徽持家汉家居工艺品有限公司 2017-09-01 CN disclosed
CN-107099193-A It is a kind of to mould the preparation method that rattan hanging basket uses coating 安徽持家汉家居工艺品有限公司 2017-08-29 CN disclosed
CN-107027836-A Mould the preparation method of rattan article maintaining agent 安徽持家汉家居工艺品有限公司 2017-08-11 CN disclosed
CN-107027836-A Mould the preparation method of rattan article maintaining agent 安徽持家汉家居工艺品有限公司 2017-08-11 CN disclosed
CN-106367246-A Agilawood and pearl soap and preparation method thereof 广州市香事文化传播有限公司 2017-02-01 CN disclosed
CN-105168669-A Traditional Chinese medicine composition for treating otitis media and preparation method and application thereof GUO WANGSHUI 2015-12-23 CN disclosed
US-9206201-B2 Boronic acid bearing liphagane compounds as inhibitors of P13K-α and/or β COUNSEL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-12-08 US disclosed
US-20150051173-A1 BORONIC ACID BEARING LIPHAGANE COMPOUNDS AS INHIBITORS OF P13K- a AND/OR B COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-02-19 US disclosed
EP-2613775-B1 N-HYDROXY-BENZAMIDES FOR THE TREATMENT OF CANCER HOFFMANN LA ROCHE (CH) 2014-07-30 EP disclosed
US-8716285-B2 N-hydroxy-benzamids for the treatment of cancer HOFFMANN-LA ROCHE INC. (US) 2014-05-06 US disclosed
EP-2613775-A1 NOVEL N-HYDROXY-BENZAMIDES FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-07-17 EP disclosed
US-20120065204-A1 NOVEL N-HYDROXY-BENZAMIDS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-03-15 US disclosed
WO-2012031993-A1 NOVEL N-HYDROXY-BENZAMIDES FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150051173-A1 BORONIC ACID BEARING LIPHAGANE COMPOUNDS AS INHIBITORS OF P13K- a AND/OR B PIK3CA, PIK3C2A, PI4KA ALDH1A1 3574/4885MAPT 4359/4885SMN1; SMN2 4468/4885
US-20120065204-A1 NOVEL N-HYDROXY-BENZAMIDS FOR THE TREATMENT OF CANCER HNMT, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HRAS ALDH1A1 158/4885MAPT 4852/4885SMN1; SMN2 3038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.